Case of clinically “aggressive” course of primary hyperparathyroidism, algorithm of differential diagnosis

Primary hyperparathyroidism (PHPT) is a significant endocrine disease caused by increased production of parathyroid hormone (PTH) by altered parathyroid glands and violation of the mechanisms of regulation of serum calcium concentrations. These changes can lead to nephrolithiasis, osteoporosis, erosive and ulcerative lesions of the gastrointestinal tract, a number of less specific symptoms (nausea, vomiting, weakness, fatigue, etc.). Etiologically, in more than 85% of cases, PHPT is a consequence of sporadic solitary adenoma or hyperplasia parathyroid glands, however, in 1–3% of cases, the cause is carcinoma of parathyroid glands , including as part of various genetic syndromes. The importance of timely examination for PHPT of patients with characteristic clinical manifestations of this disease and — with an aggressive course — alertness towards carcinomas of parathyroid glands was noted. At the same time, the severity of the clinical picture and even the presence of suspicious signs characteristic of hereditary forms of carcinomas of parathyroid glands are not always a consequence of the malignant process. We present a description of a young patient with a severe course of PHPT, multiple fractures and a voluminous tumor of the upper jaw, developed as a result of a typical adenoma of parathyroid glands. Additionally, the algorithm of pre- and postoperative differential diagnosis for such patients is highlighted.

1. Kim SJ, Shoback DM. Sporadic Primary Hyperparathyroidism. Endocrinol Metab Clin North Am. 2021;50(4):609-628. doi: https://doi.org/10.1016/j.ecl.2021.07.006

2. Dandurand K, Ali DS, Khan AA. Primary hyperparathyroidism: A narrative review of diagnosis and medical management. J Clin Med. 2021;10(8):1604. doi: https://doi.org/10.3390/jcm10081604

3. Silverberg SJ, Walker MD and Bilezikian JP. Asymptomatic primary hyperparathyroidism. J Clin Densitom. 2013;16(1):14-21. doi: https://doi.org/10.1210/jc.2014-1413

4. Clarke BL. Asymptomatic Primary Hyperparathyroidism. Front Horm Res. 2019;(51):13-22. doi: https://doi.org/10.1159/000491035

5. Mokrysheva NG, Mirnaya SS, Dobreva EA, et al. Primary hyperparathyroidism in Russia according to the registry. Problems of Endocrinology. 2019;65(5):300-310. (In Russ.). doi: https://doi.org/10.14341/probl10126

6. Mittendorf EA, McHenry CR. Parathyroid carcinoma. J Surg Oncol. 2005;89(3):136-142. doi: https://doi.org/10.1002/jso.20182

7. Apaydın T, Yavuz DG. Seven cases of parathyroid carcinoma and review of the literature. Hormones (Athens). 2021;20(1):189-195. doi: https://doi.org/10.1007/s42000-020-00220-y

8. Sampanis N, Gavriilaki E, Paschou E, et al. Ossification of the cervical ligamentum flavum and osseous brown tumor: late manifestations of primary hyperparathyroidism misdiagnosed in a case of parathyroid carcinoma. Clin Cases Miner Bone Metab. 2016;13(1):54-56. doi: https://doi.org/10.11138/ccmbm/2016.13.1.054

9. Benchafai I, Afani L, Errami N, et al. Carcinome parathyroïdien géant: difficultés diagnostiques et stratégies thérapeutiques. Pan Afr Med J. 2017;(26):211. doi: https://doi.org/10.11604/pamj.2017.26.211.8770

10. Shruti S, Siraj F. Parathyroid carcinoma: an unusual presentation of a rare neoplasm. GMS Ger Med Sci. 2017;(15):21. doi: https://doi.org/10.3205/000262

11. Ozolins A, Narbuts Z, Vanags A, et al. Evaluation of malignant parathyroid tumours in two European cohorts of patients with sporadic primary hyperparathyroidism. Langenbeck’s Arch Surg. 2016;401(7):943-951. doi: https://doi.org/10.1007/s00423-015-1361-4

12. Lairmore TC, Ball DW, Baylin SB, Wells SA. Management of pheochromocytomas in patients with multiple endocrine neoplasia type 2 syndromes. Ann Surg. 1993;217(6):595-603. doi: https://doi.org/10.1097/00000658-199306000-00001

13. Liu J, Zhan WW, Zhou JQ, Zhou W. Role of ultrasound in the differentiation of parathyroid carcinoma and benign parathyroid lesions. Clin Radiol. 2020;75(3):179-184. doi: https://doi.org/10.1016/j.crad.2019.10.004

14. Iacobone M, Carnaille B, Palazzo FF, Vriens M. Hereditary hyperparathyroidism — a consensus report of the European Society of Endocrine Surgeons (ESES). Langenbecks Arch Surg. 2015;400(8):867-886. doi: https://doi.org/10.1007/s00423-015-1342-7

15. Mamedova EO, Mokrysheva NG, Rozhinskaya LY. Hereditary forms of primary hyperparathyroidism. Osteoporosis and Bone Diseases. 2018;21(2):23-29 (In Russ.). doi: https://doi.org/10.14341/osteo9877

16. Oertli D, Udelsman R. Surgery of the thyroid and parathyroid glands. 3rd ed. Berlin: Springer; 2007. P. 311-327.

17. Schantz A, Castleman B. Parathyroid carcinoma.A study of 70 cases. Cancer. 1973;31(3):600-605. doi: https://doi.org/10.1002/1097-0142(197303)31:3<600::AID-CNCR2820310316>3.0.CO;2-0

18. Rodrigo JP, Hernandez-Prera JC, Randolph GW, et al. Parathyroid cancer: An update. Cancer Treat Rev. 2020;86(3):102012. doi: https://doi.org/10.1016/j.ctrv.2020.102012

19. Witteveen JE, van Thiel S, Romijn JA, Hamdy NAT. Therapy of endocrine disease: Hungry bone syndrome: still a challenge in the post-operative management of primary hyperparathyroidism: a systematic review of the literature. Eur J Endocrinol. 2013;168(3):R45-R53. doi: https://doi.org/10.1530/EJE-12-0528

20. Cartwright C, Anastasopoulou C. Hungry Bone Syndrome. 2022 Jul 24. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022.

21. Shetty AD, Namitha J, James L. Brown tumor of mandible in association with primary hyperparathyroidism: A case report. J Int Oral Health. 2015;7(2):50-52.

22. Rosenberg AE, Nielsen GP. Giant cell containing lesions of bone and their differential diagnosis. Curr Diagnostic Pathol. 2001;7(4):235-246. doi: https://doi.org/10.1054/cdip.2001.0080

23. Mori H, Okada Y, Arao T, et al. A case of multiple brown tumors with primary hyperparathyroidism. J Bone Miner Metab. 2013;31(1):123-127. doi: https://doi.org/10.1007/s00774-012-0364-2

24. Dhaniwala NS, Dhaniwala MN. Multiple brown tumors in a case of primary hyperparathyroidism with pathological fracture in femur. J Orthop Case Rep. 2020;10(6):49-53. doi: https://doi.org/10.13107/jocr.2020.v10.i06.1872

25. Panagopoulos A, Tatani I, Kourea HP, et al. Osteolytic lesions (brown tumors) of primary hyperparathyroidism misdiagnosed as multifocal giant cell tumor of the distal ulna and radius: a case report. J Med Case Rep. 2018;12(1):176. doi: https://doi.org/10.1186/s13256-018-1723-y

26. Mykhaylichenko VY, Karakursakov NE, Miroshnik KA. Osteoblastoclastoma – a clinical mask of primary hyperparathyroidism. Malig tumours. 2017;(1):26-29. doi: https://doi.org/10.18027/2224-5057-2017-1-26-29

27. Mokrysheva NG, AK, Krupinova YA, Mirnaya SS, et al. The clinical practice guidelines for primary hyperparathyroidism, short version. Problems of Endocrinology. 2021;67(4):94-124. (In Russ.). doi: https://doi.org/10.14341/probl12801

28. Mokrysheva NG, Krupinova JA, Mirnaya SS. Clinical, laboratory and instrumental methods of pre-surgical diagnosis of the parathyroid glands cancer. Endocrine Surgery. 2017;11(3):136-145. (In Russ.). doi: https://doi.org/10.14341/serg20173136-145

29. Kleihues P, Sobin LH. World Health Organization classification of tumors. Cancer. 2000;88(12):2887. doi: https://doi.org/10.1002/1097-0142(20000615)88:12<2887::aid-cncr32>3.0.co;2-f

30. Cetani F, Pardi E, Marcocci C. Parathyroid carcinoma. Front Horm Res. 2019;(51):63-76. doi: https://doi.org/10.1159/000491039

31. Iacobone M, Masi G, Barzon L, et al. Hyperparathyroidism-jaw tumor syndrome: a report of three large kindred. Langenbecks Arch Surg. 2009;394(5):817-825. doi: https://doi.org/10.1007/s00423-009-0511-y

32. Weaver TD, Shakir MKM, Hoang TD. Hyperparathyroidismjaw tumor syndrome. Case Rep Oncol. 2021;14(1):29-33. doi: https://doi.org/10.1159/000510002

33. Canu GL, Medas F, Cappellacci F, et al. Is extensive surgery really necessary in patients with parathyroid carcinoma? Single-centre experience and a brief review of the literature. Ann Ital Chir. 2021;92:227-233.

34. Bradley KJ, Cavaco BM, Bowl MR, et al. Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumours. Clin Endocrinol (Oxf ). 2006;64(3):299-306. doi: https://doi.org/10.1111/j.1365-2265.2006.02460.x